|
Ding WY, Rivera-Caravaca JM, Shantsila A, Marin F, Gupta D, Roldan V, Lip GYH. Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world'. Int J Clin Pract. 2021 Apr;75(4):e13888. doi: 10.1111/ijcp.13888. Epub 2020 Dec 15. PubMed PMID: 33283377.
AÑO: 2021; IF: 3.149
|
33283377
|
Camelo-Castillo A, Rivera-Caravaca JM, Orenes-Pinero E, Ramirez-Macias I, Roldan V, Lip GYH, Marin F. Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications. J Clin Med. 2021 Feb 11;10(4):715. doi: 10.3390/jcm10040715. PubMed PMID: 33670220; PubMed Central PMCID: PMC7916955.
AÑO: 2021; IF: 4.964
|
|
Ding WY, Rivera-Caravaca JM, Marin F, Li G, Roldan V, Lip GYH. Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidence. Br J Clin Pharmacol. 2022 Jan;88(1):282-289. doi: 10.1111/bcp.14961. Epub 2021 Jul 13. PubMed PMID: 34192808.
AÑO: 2022; IF: 3.4
|
|
Bravo-Perez C, Fernandez-Caballero M, Soler-Espejo E, Garcia-Torralba E, Sorigue M, Garcia-Malo MD, Jerez A, Vicente V, Roldan V, de Arriba F. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma. J Thromb Thrombolysis. 2021 Oct;52(3):848-853. doi: 10.1007/s11239-021-02407-5. Epub 2021 Mar 1. PubMed PMID: 33649980.
AÑO: 2021; IF: 2.2
|
|
Bravo-Perez C, Serna MJ, Esteban J, Fernandez-Mellid E, Fontanes-Trabazo E, Lorenzo A, Calvino-Suarez M, Minano A, Padilla J, Roldan V, Vicente V, Corral J, de la Morena-Barrio ME. Anticoagulant therapy in patients with congenital FXI deficiency. Blood Adv. 2021 Oct 26;5(20):4083-4086. doi: 10.1182/bloodadvances.2021005695. PubMed PMID: 34597376; PubMed Central PMCID: PMC8945614.
AÑO: 2021; IF: 7.637
|